Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.

Hector Corominas; I Castellví; C Diaz-Torné; L Matas; la Rosa D de; María Antonia Mangues; P Moya; Virgina Pomar; N Benito; Esther Moga; NH Sosa; Jordi Casademont; P Domingo

doi:https://doi.org/10.1097/md.0000000000025923

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.

Hector Corominas, I Castellví, C Diaz-Torné, L Matas, la Rosa D de, María Antonia Mangues, P Moya, Virgina Pomar, N Benito, Esther Moga, NH Sosa, Jordi Casademont, P Domingo

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Journal	Medicine
DOIs	https://doi.org/10.1097/md.0000000000025923
Publication status	Published - May 2021

Access to Document

https://doi.org/10.1097/md.0000000000025923

https://ddd.uab.cat/record/255701

Cite this

@article{a909cd0edea54c088dd73a7c2fb6684d,

title = "Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.",

author = "Hector Corominas and I Castellv{\'i} and C Diaz-Torn{\'e} and L Matas and de, {la Rosa D} and Mangues, {Mar{\'i}a Antonia} and P Moya and Virgina Pomar and N Benito and Esther Moga and NH Sosa and Jordi Casademont and P Domingo",

year = "2021",

month = may,

doi = "https://doi.org/10.1097/md.0000000000025923",

language = "Indefinido/desconocido",

}

TY - JOUR

T1 - Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.

AU - Corominas, Hector

AU - Castellví, I

AU - Diaz-Torné, C

AU - Matas, L

AU - de, la Rosa D

AU - Mangues, María Antonia

AU - Moya, P

AU - Pomar, Virgina

AU - Benito, N

AU - Moga, Esther

AU - Sosa, NH

AU - Casademont, Jordi

AU - Domingo, P

PY - 2021/5

Y1 - 2021/5

UR - http://europepmc.org/abstract/med/34106658

U2 - https://doi.org/10.1097/md.0000000000025923

DO - https://doi.org/10.1097/md.0000000000025923

M3 - Artículo

C2 - 34106658

ER -

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.

Access to Document

Other files and links

Cite this